11-2909704-CG-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_002555.6(SLC22A18):c.531del(p.Tyr178ThrfsTer51) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000879 in 1,529,200 control chromosomes in the GnomAD database, including 11 homozygotes. Variant has been reported in ClinVar as Benign (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0047 ( 7 hom., cov: 33)
Exomes 𝑓: 0.00046 ( 4 hom. )
Consequence
SLC22A18
NM_002555.6 frameshift
NM_002555.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.463
Genes affected
SLC22A18 (HGNC:10964): (solute carrier family 22 member 18) This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene is imprinted, with preferential expression from the maternal allele. Mutations in this gene have been found in Wilms' tumor and lung cancer. This protein may act as a transporter of organic cations, and have a role in the transport of chloroquine and quinidine-related compounds in kidney. Several alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 11-2909704-CG-C is Benign according to our data. Variant chr11-2909704-CG-C is described in ClinVar as [Benign]. Clinvar id is 3050688.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00466 (708/152088) while in subpopulation AFR AF= 0.016 (666/41500). AF 95% confidence interval is 0.015. There are 7 homozygotes in gnomad4. There are 329 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A18 | NM_002555.6 | c.531del | p.Tyr178ThrfsTer51 | frameshift_variant | 5/11 | ENST00000649076.2 | NP_002546.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A18 | ENST00000649076.2 | c.531del | p.Tyr178ThrfsTer51 | frameshift_variant | 5/11 | NM_002555.6 | ENSP00000497561 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00464 AC: 705AN: 151966Hom.: 7 Cov.: 33
GnomAD3 genomes
AF:
AC:
705
AN:
151966
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000738 AC: 94AN: 127446Hom.: 0 AF XY: 0.000605 AC XY: 43AN XY: 71050
GnomAD3 exomes
AF:
AC:
94
AN:
127446
Hom.:
AF XY:
AC XY:
43
AN XY:
71050
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000462 AC: 636AN: 1377112Hom.: 4 Cov.: 35 AF XY: 0.000412 AC XY: 280AN XY: 679912
GnomAD4 exome
AF:
AC:
636
AN:
1377112
Hom.:
Cov.:
35
AF XY:
AC XY:
280
AN XY:
679912
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00466 AC: 708AN: 152088Hom.: 7 Cov.: 33 AF XY: 0.00442 AC XY: 329AN XY: 74354
GnomAD4 genome
AF:
AC:
708
AN:
152088
Hom.:
Cov.:
33
AF XY:
AC XY:
329
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SLC22A18-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 04, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at